Werewolf Therapeutics, Inc. (HOWL) Financial Statements (2026 and earlier)

Company Profile

Business Address 200 TALCOTT AVENUE
WATERTOWN, MA 02472
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments57,050110,995134,343129,315157,531
Cash and cash equivalent57,050110,995134,343129,315157,531
Restricted cash and investments  211 100
Receivables   1,3506,928 
Other undisclosed current assets1,5362,0712,4663,9573,437
Total current assets:58,586113,066138,370140,200161,068
Noncurrent Assets
Operating lease, right-of-use asset5,2166,0016,8888,46313,412
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization4,6886,3227,9588,9882,913
Restricted cash and investments 9011,22021,0231,2141,208
Other noncurrent assets 53205941,380649
Total noncurrent assets:10,81013,86336,46320,04518,182
TOTAL ASSETS:69,396126,929174,833160,245179,250
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,16113,62310,19615,37310,802
Accounts payable7543,0351,3361,2212,037
Accrued liabilities5,40710,5888,86014,1528,765
Deferred revenue   9076,532 
Debt28,236 6,667  
Other undisclosed current liabilities1,7511,5571,6082,0841,072
Total current liabilities:36,14815,18019,37823,98911,874
Noncurrent Liabilities
Long-term debt and lease obligation  26,09532,656 14,589
Long-term debt, excluding current maturities  26,09532,656  
Liabilities, other than long-term debt8,44312,26411,42513,919 
Deferred revenue   4331,128 
Other liabilities    191 
Operating lease, liability7,6849,43510,99212,60014,589
Derivative instruments and hedges, liabilities7592,829   
Other undisclosed noncurrent liabilities     (14,589)
Total noncurrent liabilities:8,44338,35944,08113,91914,589
Total liabilities:44,59153,53963,45937,90826,463
Equity
Equity, attributable to parent24,80573,390111,374122,337152,787
Common stock55432
Additional paid in capital500,210487,973455,443429,039405,680
Accumulated deficit(475,410)(414,588)(344,073)(306,705)(252,895)
Total equity:24,80573,390111,374122,337152,787
TOTAL LIABILITIES AND EQUITY:69,396126,929174,833160,245179,250

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenues
(Sublease Income)
  3981,562834 
Gross profit:  3981,562834 
Operating expenses(60,677)(75,479)(60,446)(72,457)(50,087)
Other undisclosed operating income  1,48718,38115,567 
Operating loss:(60,677)(73,594)(40,503)(56,056)(50,087)
Nonoperating income (expense)(145)3,0793,1352,246104
Investment income, nonoperating3,1086,6737,4161,908104
Other nonoperating income (expense)2,0211,615(1,142)  
Interest and debt expense(5,274)(553)(3,139)  
Loss from continuing operations:(66,096)(71,068)(40,507)(53,810)(49,983)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(49,983)
Net loss:(66,096)(71,068)(40,507)(53,810)(49,983)
Other undisclosed net income attributable to parent5,2745533,139  
Net loss attributable to parent:(60,822)(70,515)(37,368)(53,810)(49,983)
Preferred stock dividends and other adjustments     (151,942)
Net loss available to common stockholders, basic:(60,822)(70,515)(37,368)(53,810)(201,925)
Interest on convertible debt776493   
Other undisclosed net loss available to common stockholders, diluted(2,070)(1,621)   
Net loss available to common stockholders, diluted:(62,116)(71,643)(37,368)(53,810)(201,925)

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Net loss:(66,096)(71,068)(40,507)(53,810)(49,983)
Comprehensive loss, net of tax, attributable to parent:(66,096)(71,068)(40,507)(53,810)(49,983)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: